ReviewBioengineering (Basel, Switzerland)2025
Application of CAD Systems in Breast Cancer Diagnosis Using Machine Learning Techniques: An Overview of Systematic Reviews.
Review in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is the second-leading cause of mortality among women worldwide. However, early detection and diagnosis significantly improve treatment outcomes. In recent years, Computer-Aided Diagnosis (CAD) systems, which leverage Artificial Intelligence (AI) techniques, have emerged as valuable tools for assisting radiologists in the accurate and efficient analysis of medical images. Following the PRISMA guidelines, this study presents the first meta-review that synthesizes evidence from 48 systematic reviews published between 2015 and January 2025. In contrast to previous reviews, which often focus on a single imaging modality or clinical task, our work provides a comprehensive overview of imaging techniques, publicly available datasets, AI methods, and clinical tasks employed in CAD systems for breast cancer diagnosis and treatment. Our analysis shows that mammography is the most frequently applied imaging modality, while DDSM, MIAS, and INBreast are the most commonly used datasets. Among clinical tasks, the detection and classification of breast lesions are the most extensively studied, with deep learning approaches being increasingly prevalent. However, current CAD systems face notable limitations, including the lack of large and diverse datasets, limited transparency and interpretability of AI-based decisions, and restricted clinical integration. By highlighting both the achievements and the limitations, this systematic review aims to support medical professionals and technical researchers in understanding the current state of CAD systems in breast cancer care and to provide guidance for future research directions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.